title: Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells.
abstract: The thymidine analog 5-bromodeoxyuridine (BrdU) suppresses pigmentation and tyrosinase activity in Syrian hamster melanoma cells W1-1-1. Studies on the molecular mechanism of suppression of pigmentation indicated that BrdU treatment affects the level of tyrosinase gene transcripts. No detectable tyrosinase message was found by Northern blot analysis in cells cultured in the presence of BrdU at concentrations even as low as 0.2 microM. The level of tyrosinase mRNA was found to reflect the level of pigmentation and tyrosinase activity. Studies with dibutyryl cyclic AMP (cAMP) showed that it inhibited pigment synthesis in W1-1-1 cells. With increasing concentrations of cAMP ranging from 10 microM to 300 microM, pigmentation and tyrosinase activity decreased progressively. This inhibition was found to be associated with a corresponding decrease in the level of tyrosinase mRNA. W1-1-1 cells were found not to respond to melanocyte stimulating hormone (MSH). There was no change in pigmentation, tyrosinase activity, or tyrosinase mRNA level in W1-1-1 cells in the presence of MSH. Similarly, theophylline, a phosphodiesterase inhibitor, had no effect on pigmentation or tyrosinase activity in W1-1-1 cells.
authors.affiliation: Department of Genetics, University of Illinois College of Medicine, Chicago 60612.
authors.forename: S
authors.initials: S
authors.lastname: Rauth
authors.forename: G E
authors.initials: GE
authors.lastname: Hoganson
authors.forename: R L
authors.initials: RL
authors.lastname: Davidson
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D003994:Bucladesine / Q000494:pharmacology; D006224:Cricetinae; D003412:Cricetulus; D000242:Cyclic AMP / Q000494:pharmacology*; D015870:Gene Expression / Q000187:drug effects; D066298:In Vitro Techniques; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology; D008546:Melanoma, Experimental / Q000201:enzymology*; D014442:Monophenol Monooxygenase / Q000235:genetics*; D010858:Pigmentation / Q000187:drug effects; D012333:RNA, Messenger / Q000235:genetics; D014407:Tumor Cells, Cultured
chemical_list: D012333:RNA, Messenger; D003994:Bucladesine; D009074:Melanocyte-Stimulating Hormones; D000242:Cyclic AMP; D014442:Monophenol Monooxygenase; D001973:Bromodeoxyuridine